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SUMMARY: The mediterranean diet (MD) reduced the risk of colorectal cancer (CRC), and olive oil, the 
primary source of fat in the MD, has also been found to have a protective effect. However, animals fed with 
oleic acid present a high number of intestinal tumours, suggesting that oleic acid and olive oil consumption can 
exert different effects on CRC. Considering that extra virgin olive oil (EVOO) is a complex mix of fatty acids 
and minor compounds such as polyphenols, hydrocarbons, phytosterols and triterpenes; and that these com-
pounds have antioxidant activity and consequently they can modulate the arachidonic acid (AA) cascade and 
eicosanoid synthesis. This review analyzes the state of the art of olive oil components on the AA cascade and 
cellular mechanism involved in CRC such as intestinal epithelial cell growth/apoptosis, to understand the fact 
that the consumption of seed oils with high oleic content or EVOO will probably have different effects on CRC 
development.
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RESUMEN: Efecto de los componentes del aceite de oliva virgen extra en la cascada del ácido araquidónico, el 
cáncer colorrectal y la proliferación de células de cáncer de colon. La dieta Mediterranea (DM) y el aceite de oliva 
reducen el riesgo de cáncer colorrectal (CCR). Sin embargo, animales alimentados con dietas ricas en ácido 
oleico presentan un elevado número de tumores intestinales, lo que sugiere que el consumo de ácido oleico y 
aceite de oliva pueden tener efectos diferentes sobre el desarrollo de CCR. Considerando que el aceite de oliva 
extra virgen (AOEV) es una compleja mezcla de ácidos grasos y compuestos minoritarios como polifenoles, 
lignanos, hidrocarburos, fitoesteroles y triterpenos; y que algunos de estos compuestos son antioxidantes y 
modulan la cascada del ácido araquidónico (AA) y la producción de eicosanoides. Analizamos la información 
existente sobre el efecto de los componentes del AOEV sobre la cascada del AA y los mecanismos implicados en 
el CCR como el crecimiento de las células epiteliales intestinales/apoptosis, lo que nos permitirá entender por 
qué el consumo de aceites de semillas altos en oleico o AOEV probablemente tendrán diferentes efectos sobre 
el desarrollo del CCR.
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1.  ROLE OF THE ARACHIDONIC ACID 
CASCADE ON INTESTINAL EPITHELIAL 
CELL GROWTH AND COLORECTAL 
CANCER
Considerable amounts of arachidonic acid (AA) 
are found esterified at the sn-2 position of the phos-
pholipid biomembranes. Under physiological condi-
tions, the amount of free intracellular AA available 
is quite small, but numerous stimuli can induce AA 
release through phospholipase A2(PLA2) activation. 
Then, AA can be metabolized by cyclooxygenases 
(COXs) to produce prostaglandins (PGs), by lipoxy-
genases (LOXs) to synthesize leukotrienes (LTs) 
and hydroxyeicosatetraenoic acids (HETEs), and 
by cytochrome P-450 pathway to produce HETEs 
and epoxieicosatetraenoic acids (EETs) (Figure 1). 
These bioactive lipids have pleitropic effects even 
though they were classically considered inflamma-
tory mediators.
Today, the causal relationship between inflam-
mation, innate immunity and cancer is more widely 
accepted; nevertheless, many of the molecular and 
cellular mechanisms mediating this relationship 
remain unresolved. However, there is now evidence 
that inflammatory mediators have a powerful effect 
on tumor development. Early in the neoplastic pro-
cess, eicosanoids produced by the AA cascade could 
be powerful tumor promoters, producing an attrac-
tive environment for tumor growth and promoting 
angiogenesis in the intestinal mucosa (Ferrer and 
Moreno, 2010).
Studies in the early 1980s indicated that non-
steroidal anti-inflammatory drugs (NSAIDs) were 
chemo preventive in animal models of  colorectal 
cancer (CRC). In 1991, Thun et al. reported that 
aspirin reduces the relative risk and mortality of 
CRC. Even more relevant for the clinician were 
subsequent studies that demonstrated that NSAID 
therapy can cause the regression of  adenoma in 
patients with familial adenomatous polyposis 
(Koehne and Dubois, 2004). Furthermore, COX-2 
is elevated in CRC, with the subsequent increase of 
PGE2 and 6-keto PGF1α levels (Moran et al., 2004). 
Using an elegant experimental model of  CRC 
induced by genetic manipulation, Oshima et al. 
(1996) reported that COX-2 is located in the stro-
mal component and may promote tumor growth by 
producing bioactive PGs that affect tumor growth 
in a paracrine fashion.
Figure 1. Arachidonic acid cascade. This scheme illustrates the main elements of the AA cascade including the main enzymes and 
metabolites of cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P-450 (Cyt P-450) pathways: PGES, prost-aglandin E 
synthase; PGDS, prostaglandin D synthase; PGFS, prostaglandin F synthase; PGIS, prostaglandin I synthase; TXAS, thromboxane 
A synthase; LTA4H, leukotriene A4 hydrolase; LTC4S, leukotriene C4 synthase.
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The beneficial effects of dietary manipulation of 
the AA content in the bio-membranes of animals 
that spontaneously induce polyps (APCmin mice) 
suggest that AA is a key element involved in tumori-
genesis (Petrik et al., 2000). Inducing a cytosolic 
PLA2 deletion in APC
min mice, Hong et al. (2001) 
demonstrated the pivotal role of these enzymes 
involved in the AA release in small intestine polyp 
formation. These findings support the hypoth-
esis that the anti-tumorigenic effects of NSAIDs 
are related to the impairment of PG production. 
However, these explanations have lacked molecu-
lar details, in largely as a consequence of a poor 
understanding of the role of PG receptors. In the 
last decade, important findings were obtained with 
respect to this point. Targeted deletion of the EP1 
receptor of PGE2 reduced the number of colonic 
lesions in APCmin-induced polyp formation that was 
also reduced by a specific EP1 antagonist (Watanabe 
et al., 1999), whereas EP4 deletion reduced the tumor 
size. Considering all of this together, we have a com-
plete picture of the main elements involved in the 
effects of the AA cascade on epithelial cell growth 
in physiological and patho-physiological conditions: 
AA is released by PLA2, then it is metabolized by 
COX-1/COX-2 to produce bioactive eicosanoids 
such as PGE2, which interact with specific receptors 
(EP1 and EP4) and activate cell signaling pathways 
involved in the control of intestinal epithelial cell 
growth (Sanchez and Moreno, 2002; Cabral et al., 
2013; Cabral et al., 2014).
Cianchi et al. (2006) reported that the two major 
metabolic pathways of the AA cascade, COX and 
5-LOX, are simultaneously up-regulated in CRC. 
Interestingly, an inhibition of either COX or 5-LOX 
alone resulted in the activation of the other pathway, 
and consequently, combined treatment with COX 
and 5-LOX inhibitors produced greater inhibition 
of tumor cell proliferation. A high expression of the 
BLT1 receptor of LTB4 (Ihara et al., 2007) and the 
CystLT1 receptor of LTD4was detected in human 
colon cancer tissues, whereas CysLT2 receptor expres-
sion was reduced in colon cancer and was associated 
with poor prognosis, due to its capacity to induce dif-
ferentiation and growth inhibition (Magnusson et al., 
2007). Recently, we observed that several LOX metab-
olites from AA and linoleic acid such as LTB4, LTD4, 
5-HETE, 12-HETE, 15-HETE and 13-hydroxyocta-
decanoic acid are involved in the control of CRC cell 
line proliferation (Cabral et al., 2013; Cabral et al., 
2014; Martín-Venegas et al., 2014; Cabral et al., 2015).
2.  EFFECT OF THE MEDITERRANEAN DIET 
AND OLIVE OIL ON COLORECTAL CANCER
CRC is the third most commonly diagnosed 
cancers in developed countries, and is the sec-
ond cause of  cancer-related deaths. Although a 
great effort has been made toward developing 
detection and surgical strategies, there has been 
little improvement in the outcome for patients with 
advanced disease. Obviously, many elements such 
as the dysregulation of  intestinal epithelial cell 
growth/apoptosis, angiogenesis and metastasis are 
involved in the development of  CRC. Enhancement 
of  cell proliferation is widely understood to be an 
important factor determining carcinogenesis. In 
the colon, an increased numbers of  cycling cells 
or mitoses leading to expansion of  the cell prolif-
eration zone and increased crypt height as well as 
depressed apoptosis are considered risk factors for 
tumor development.
The traditional Mediterranean diet (MD) is 
widely recognized as one of  the healthiest in the 
world and it is likely that the adoption of  this diet 
would lead to a significant reduction in the inci-
dence of  many chronic diseases (Sofi et al., 2011). 
This recent meta-analysis of  prospective cohort 
studies concluded that the MD is responsible of 
a significant reduction in death that included the 
impairment in the incidence of  neo-plastic diseases. 
In this sense, updated reports from a large cohort 
such as the European Prospective Investigation 
into Cancer and Nutrition (EPIC) have found a 
lower overall cancer risk among individuals with 
greater adherence to the MD (Couto et al., 2011). 
Similar results were obtained in the large cohort 
belonging to the National Institutes of  Health 
(Reedy et al., 2008).
It is the consumption of  olive oil, more than 
any other single factor that distinguishes the tradi-
tional MD from other dietary patterns, and it has 
been related to the reduced risk of  various neo-
plasms including CRC (Pelucchi et al., 2011). It 
is important to consider that extra virgin olive oil 
(EVOO) is a complex mix containing fatty acids 
such as oleic acid and minor compounds such 
as simple phenols (tyrosol and hydroxytyrosol), 
adhehydic secoiridoids (oleuropein), flavonoids 
and lignans (pinoresinol) as well as hydrocarbons 
(scualene), phytosterols (β-sitosterol) and triter-
penes (maslinic acid) (Table 1), and that some of 
these compounds may modulate the mechanism 
Table 1. Main components of extra virgin olive oil and 
their daily consumption by humans
Compounds Content Daily consumption
Oleic acid 550–850 g/Kg 25–40 g
Linoleic acid 50–200 g/Kg 2–10 g
Hydrocarbons 1200–7500 mg/kg 50–300 mg
Phytosterols 1800–2500 mg/kg 100–150 mg
Polyphenols up to 1000 mg/kg 50 mg
Tocopherols 100–300 mg/kg 5–15 mg
Triterpens 150–1000 mg/kg 10–50 mg
Lignans up to 100 mg/kg 5 mg
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involved in the pathogenesis of  CRC such as intes-
tinal epithelial cell growth as well as apoptosis, 
angiogenesis and metastasis. Thus, flavonoid and 
lignan intakes have been inversely associated with 
CRC risk in several case-control studies, and The 
Polyp Prevention Trial Study reported that high 
intakes of  flavonols and isoflavones were related 
to a decreased risk in advanced CRC. Here, we 
analyze the effect of  oleic acid and representa-
tive EVOO minor bioactive compounds on oxida-
tive stress, AA cascade and colon cancer cell line 
growth, opening the way to a more precise under-
standing of  the molecular basis of  the action of 
EVOO on CRC.
3.  EFFECT OF OLIVE OIL COMPONENTS ON 
OXIDATIVE STRESS AND AA CASCADE
Olive oil contains a high amount of  oleic acid 
and only a small amount of  linoleic acid, the pre-
cursor of  AA in mammals. Thus, olive oil pro-
vides monounsaturated fatty acids, which are not 
as readily oxidized as the polyunsaturated fatty 
acids, and consequently reduces membrane suscep-
tibility to lipid peroxidation. Furthermore, Bartoli 
et al. (2000) reported that a diet rich in olive oil 
significantly reduced AA concentration in tissues, 
changes that might be responsible for the impair-
ment of  oxidative stress and the synthesis of  AA 
metabolites (Moreno et al., 2001). There is a well-
established inverse relationship between the dietary 
intake of  antioxidant-rich foods and the incidence 
of  human diseases. EVOO contains numerous 
minor components with antioxidant activity such 
as polyphenols. These facts are consistent with the 
observation that the minor components of  olive oil 
protect against DNA oxidation and lipid peroxida-
tion (Mitjavila et al., 2013). Among the minor com-
ponents of  EVOO, phenolic compounds are those 
most extensively studied. However, it should not be 
overlooked that EVOO contains other components 
that are quantitatively more significant such as 
hydrocarbons and phytosterols. Thus, β-sitosterol 
inhibits ROS production (Moreno, 2003) through 
the enhancement of  antioxidant enzymes such as 
Mn superoxide dismutase and glutathione peroxi-
dase (Vivancos and Moreno, 2005). Interestingly, 
polyphenols and phytosterols can modulate oxi-
dative stress through distinct and complemen-
tary mechanisms that induce synergistic effects 
(Vivancos and Moreno, 2005).
We must consider that the cellular redox state 
may act as a molecular switch that regulates the 
activity of  many enzymes and genes. In this way, 
ROS are involved in the PLA2 activation, AA 
release and eicosanoid synthesis (Martínez and 
Moreno, 2001). Consequently, foods rich in anti-
oxidants such as EVOO modulate cellular oxida-
tive stress, the AA cascade and reduce eicosanoid 
synthesis (Moreno et al., 2001), events that may be 
specifically modulated by bioactive components 
of  EVOO such as polyphenols and phytosterols 
(Moreno, 2003; Vivancos and Moreno, 2008).
4.  EFFECT OF OLEIC ACID ON 
COLORECTAL CANCER AND COLON 
CANCER CELL LINE PROLIFERATION
In recent decades, epidemiological data indi-
cated a key role from the amount of dietary fat in 
the pathogenesis of different neoplasms as CRC 
(Bartsch et al., 1999). Several experimental mod-
els have also provided evidence that the fatty acid 
composition in the diet is a major determinant in 
the risk of tumor development. However, the pre-
cise mechanisms underlying their inflammatory/
anti-inflammatory, tumorigenic/anti-tumorigenic 
or immune-modulating effects remain largely 
unknown. Interestingly, dietary olive oil modulates 
the lipid membrane composition and the produc-
tion of inflammatory mediators including PGs and 
nitric oxide (Moreno et al., 2001) as we mentioned 
above.
Olive oil has been found to have a slight protec-
tive effect on CRC development (Braga et al., 1998), 
while monounsaturated fat intake appeared uninflu-
ential (Franceschi et al., 1998). Interestingly, Hansen 
Petrik et al., (2000) reported that ApcMin/+ mice fed 
with an oleic acid diet presented a high number of 
intestinal tumors, whereas, when the diet was pre-
pared with olive oil, Barone and co-workers (2014) 
observed a decrease in polyp number and polyp vol-
ume, with respect to a soybean oil diet (PUFA rich). 
These important discrepancies put into consider-
ation the fact that oleic acid and olive oil can exert 
different effects on CRC. In this sense, we recently 
observed that oleic acid induces intestinal epithe-
lial cell growth whereas oleic acid in the presence of 
EVOO components such as hydroxytyrosol, oleuro-
pein, pinoresinol or maslinic acid did not have this 
mitogenic action (Martínez-Hovelman et al., 2013).
5.  EFFECTS OF EXTRA VIRGIN OLIVE 
OIL MINOR COMPONENTS ON 
ARACHIDONIC ACID CASCADE 
AND COLON CANCER CELL LINE 
PROLIFERATION
Traditionally the beneficial effects of olive oil 
have been ascribed to its oleic acid content. However, 
a wide range of evidence indicates that the beneficial 
effects of EVOO intake are due to the minor bioac-
tive compounds present in the unsaponifiable frac-
tion. Thus, EVOO polyphenols such as tyrosol and 
hydroxytyrosol are potent antioxidants and radical 
scavengers (Visioli et al., 1998) that can inhibit COX 
pathway and the synthesis of PGs (Moreno 2003; 
Vivancos and Moreno 2008) as well as the synthesis 
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of LTs by the LOX pathway (De la Puerta et al., 
1999; Moreno 2003).The main phenolic compounds 
present in EVOO, oleuropein and hydroxytyrosol, 
induce a reduction in proliferation and an increase 
in apoptosis in human colorectal cancer cell lines by 
down regulating FAS activity (Notarnicola et al., 
2011). In this way, we recently reported that EVOO 
lignans such as pinoresinol, EVOO triterpenes such 
as maslinic acid and EVOO hydrocarbons such as 
squalene inhibited cell proliferation and DNA syn-
thesis induced by oleic acid in adenocarcinoma cell 
cultures (Martínez-Hovelman et al., 2013).
6.  CONCLUSIONS AND FUTURE 
PERPECTIVES
In conclusion, oleic acid and oleic acid in the 
presence of the representative minor components 
of EVOO have different effects on oxidative stress, 
the AA cascade and intestinal epithelial cell growth 
(Figure 2) and consequently the consumption of 
seed oils, seed oils with high oleic content or EVOO 
will probably have different effects on CRC develop-
ment. Additional research is necessary to clarify this 
point with important consequences for nutrition, 
health and economy. Furthermore, a profound clini-
cal and experimental study on the effect of EVOO’s 
minor components regarding CRC is also necessary 
to elucidate the mechanisms involved.
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